{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:46:33Z","timestamp":1791632793388,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12325-025-03302-8","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T07:36:15Z","timestamp":1753083375000},"page":"4556-4570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-3324","authenticated-orcid":false,"given":"Kent A.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-6290","authenticated-orcid":false,"given":"Jenny","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1895-6475","authenticated-orcid":false,"given":"Nicola","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-7494","authenticated-orcid":false,"given":"Sergio","family":"Vano-Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-0372","authenticated-orcid":false,"given":"Simran","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-8111","authenticated-orcid":false,"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1021","authenticated-orcid":false,"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-8008","authenticated-orcid":false,"given":"Ernest H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"2","key":"3302_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","volume":"14","author":"N Islam","year":"2015","unstructured":"Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81\u20139.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3302_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"HH Lee","year":"2020","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(3):675\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3302_CR3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","volume":"134","author":"SA Mirzoyev","year":"2014","unstructured":"Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009. J Invest Dermatol. 2014;134(4):1141\u20132.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3302_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/ijt.ijt_99_17","volume":"10","author":"E Darwin","year":"2018","unstructured":"Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology. 2018;10(2):51\u201360.","journal-title":"Int J Trichology"},{"issue":"2","key":"3302_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177\u201388 (quiz 89\u201390).","journal-title":"J Am Acad Dermatol"},{"key":"3302_CR6","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Prim. 2017;3:17011.","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"3302_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ajd.12941","volume":"60","author":"WC Cranwell","year":"2019","unstructured":"Cranwell WC, Lai VW, Photiou L, Meah N, Wall D, Rathnayake D, et al. Treatment of alopecia areata: an Australian expert consensus statement. Australas J Dermatol. 2019;60(2):163\u201370.","journal-title":"Aust J Dermatol"},{"issue":"3","key":"3302_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","volume":"55","author":"A Tosti","year":"2006","unstructured":"Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55(3):438\u201341.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3302_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II treatment. J Am Acad Dermatol. 2010;62(2):191\u2013202 (quiz 3\u20134).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3302_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","volume":"76","author":"LY Liu","year":"2017","unstructured":"Liu LY, Craiglow BG, Dai F, King BA. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients. J Am Acad Dermatol. 2017;76(1):22\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3302_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","volume":"86","author":"BA King","year":"2022","unstructured":"King BA, Mesinkovska NA, Craiglow B, Kindred C, Ko J, McMichael A, et al. Development of the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022;86(2):359\u201364.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3302_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jaad.2016.04.035","volume":"75","author":"LY Liu","year":"2016","unstructured":"Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review. J Am Acad Dermatol. 2016;75(4):806\u201312.e3.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3302_CR13","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","volume":"20","author":"N Mesinkovska","year":"2020","unstructured":"Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of illness in alopecia areata: a cross-sectional online survey study. J Investig Dermatol Symp Proc. 2020;20(1):S62\u20138.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"10","key":"3302_CR14","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.jid.2022.02.019","volume":"142","author":"M Senna","year":"2022","unstructured":"Senna M, Ko J, Glashofer M, Walker C, Ball S, Edson-Heredia E, et al. Predictors of QoL in patients with alopecia areata. J Invest Dermatol. 2022;142(10):2646\u201350.e3.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3302_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjd.14497","volume":"175","author":"F Rencz","year":"2016","unstructured":"Rencz F, Gul\u00e1csi L, P\u00e9ntek M, Wikonk\u00e1l N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol. 2016;175(3):561\u201371.","journal-title":"Br J Dermatol"},{"issue":"1","key":"3302_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13555-022-00864-1","volume":"13","author":"K Gandhi","year":"2023","unstructured":"Gandhi K, Shy ME, Ray M, Fridman M, Vaghela S, Mostaghimi A. The association of alopecia areata-related emotional symptoms with work productivity and daily activity among patients with alopecia areata. Dermatol Ther (Heidelb). 2023;13(1):285\u201398.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"3302_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13555-021-00648-z","volume":"12","author":"KW Wyrwich","year":"2022","unstructured":"Wyrwich KW, Winnette R, Bender R, Gandhi K, Williams N, Harris N, et al. Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) questionnaire in adults and adolescents with alopecia areata. Dermatol Ther (Heidelb). 2022;12(1):149\u201366.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"3302_CR18","first-page":"1","volume":"11","author":"R Winnette","year":"2021","unstructured":"Winnette R, Martin S, Harris N, Deal L. Development of the Alopecia Areata Patient Priority Outcomes instrument: a qualitative study. Dermatol Ther (Heidelb). 2021;11(4):1\u201315.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"3302_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","volume":"12","author":"B King","year":"2022","unstructured":"King B, Senna MM, Ohyama M, Tosti A, Sinclair RD, Ball S, et al. Defining severity in alopecia areata: current perspectives and a multidimensional framework. Dermatol Ther (Heidelb). 2022;12:825\u201334.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"3302_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s13555-022-00702-4","volume":"12","author":"HL Gelhorn","year":"2022","unstructured":"Gelhorn HL, Cutts K, Edson-Heredia E, Wright P, Delozier A, Shapiro J, et al. The relationship between patient-reported severity of hair loss and health-related quality of life and treatment patterns among patients with alopecia areata. Dermatol Ther (Heidelb). 2022;12(4):989\u201397.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"3302_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/120347540100500202","volume":"5","author":"MM Chren","year":"2001","unstructured":"Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105\u201310.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"3302_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"3302_CR23","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jid.2020.05.079","volume":"140","author":"L Naldi","year":"2020","unstructured":"Naldi L, Cazzaniga S. Research techniques made simple: latent class analysis. J Invest Dermatol. 2020;140(9):1676\u201380.e1.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"3302_CR24","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: Disease-Specific Programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"3302_CR25","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, Doslikova K, Davis VA, Karavali M, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"key":"3302_CR26","unstructured":"European Pharmaceutical Market Research Association. Code of Conduct. 2022. https:\/\/www.ephmra.org\/sites\/default\/files\/2022-08\/EPHMRA%202022%20Code%20of%20Conduct.pdf. Accessed 6 May 2024."},{"issue":"5","key":"3302_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"5\u20136","key":"3302_CR28","first-page":"767","volume":"240","author":"R Sinclair","year":"2024","unstructured":"Sinclair R, Law EH, Zhang X, Zhang F, Napatalung L, Zwillich SH, et al. Patient-reported satisfaction with hair regrowth in a study of ritlecitinib in alopecia areata: results from ALLEGRO-2b\/3. Dermatology. 2024;240(5\u20136):767\u201377.","journal-title":"Dermatology"},{"issue":"6","key":"3302_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"3302_CR30","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/jdv.18848","volume":"37","author":"M Prendke","year":"2023","unstructured":"Prendke M, Kanti-Schmidt V, Wilborn D, Hillmann K, Singh R, Vogt A, et al. Quality of life in children and adolescents with alopecia areata\u2014a systematic review. J Eur Acad Dermatol Venereol. 2023;37(8):1521\u201334.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"3302_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijwd.2017.11.007","volume":"4","author":"DS Davis","year":"2018","unstructured":"Davis DS, Callender VD. Review of quality of life studies in women with alopecia. Int J Womens Dermatol. 2018;4(1):18\u201322.","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"3302_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bodyim.2009.03.004","volume":"6","author":"N Welsh","year":"2009","unstructured":"Welsh N, Guy A. The lived experience of alopecia areata: a qualitative study. Body Image. 2009;6(3):194\u2013200.","journal-title":"Body Image"},{"issue":"3","key":"3302_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamadermatol.2023.5869","volume":"160","author":"A Moussa","year":"2024","unstructured":"Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, et al. The Alopecia Areata Severity and Morbidity Index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity. JAMA Dermatol. 2024;160(3):341\u201350.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"3302_CR34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13555-021-00512-0","volume":"11","author":"A Mostaghimi","year":"2021","unstructured":"Mostaghimi A, Napatalung L, Sikirica V, Winnette R, Xenakis J, Zwillich SH, et al. Patient perspectives of the social, emotional and functional impact of alopecia areata: a systematic literature review. Dermatol Ther (Heidelb). 2021;11(3):867\u201383.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"3302_CR35","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/bjd.17463","volume":"180","author":"L Davey","year":"2019","unstructured":"Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol. 2019;180(6):1377\u201389.","journal-title":"Br J Dermatol"},{"issue":"1","key":"3302_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s41687-020-00240-7","volume":"4","author":"NVJ Aldhouse","year":"2020","unstructured":"Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, et al. \u201c\u2019You lose your hair, what\u2019s the big deal?\u2019 I was so embarrassed, I was so self-conscious, I was so depressed:\u201d a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020;4(1):76.","journal-title":"J Patient Rep Outcomes"},{"issue":"11","key":"3302_CR37","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s13555-023-00997-x","volume":"13","author":"D Tha\u00e7i","year":"2023","unstructured":"Tha\u00e7i D, Tziotzios C, Ito T, Ko J, Karada\u011f AS, Fang H, et al. Hair loss profiles and ritlecitinib efficacy in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b\/3 study. Dermatol Ther (Heidelb). 2023;13(11):2621\u201334.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"3302_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","volume":"14","author":"ST Lanza","year":"2013","unstructured":"Lanza ST, Rhoades BL. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev Sci. 2013;14(2):157\u201368.","journal-title":"Prev Sci"},{"issue":"7","key":"3302_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11882-015-0542-0","volume":"15","author":"R Howard","year":"2015","unstructured":"Howard R, Rattray M, Prosperi M, Custovic A. Distinguishing asthma phenotypes using machine learning approaches. Curr Allergy Asthma Rep. 2015;15(7):38.","journal-title":"Curr Allergy Asthma Rep"},{"key":"3302_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.psychres.2018.03.003","volume":"266","author":"CM Ulbricht","year":"2018","unstructured":"Ulbricht CM, Chrysanthopoulou SA, Levin L, Lapane KL. The use of latent class analysis for identifying subtypes of depression: a systematic review. Psychiatry Res. 2018;266:228\u201346.","journal-title":"Psychiatry Res"},{"issue":"3","key":"3302_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027689","volume":"12","author":"R Nakamaru","year":"2023","unstructured":"Nakamaru R, Shiraishi Y, Niimi N, Kohno T, Nagatomo Y, Takei M, et al. Phenotyping of elderly patients with heart failure focused on noncardiac conditions: a latent class analysis from a multicenter registry of patients hospitalized with heart failure. J Am Heart Assoc. 2023;12(3): e027689.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3302_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/bjd\/ljad410","volume":"190","author":"CV Chalitsios","year":"2024","unstructured":"Chalitsios CV, Meena D, Manou M, Papagiannopoulos C, Markozannes G, Gill D, et al. Multiple long-term conditions in people with psoriasis: a latent class and bidirectional Mendelian randomization analysis. Br J Dermatol. 2024;190(3):364\u201373.","journal-title":"Br J Dermatol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:57:01Z","timestamp":1757264221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03302-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KA Hanson was a paid consultant to Pfizer during the period in which the work for this manuscript was conducted. The author is no longer affiliated with the company. J Austin, P Anderson, S Marwaha, and J Piercy are employees of Adelphi Real World. N Clayton has no competing interests. S Vano-Galvan reports consulting fees and payment\/honoraria from Pfizer and Lilly. SK Kurosky, A Lejeune, and EH Law are employees of and hold stock or stock options in Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data were collected according to European Pharmaceutical Marketing Research Association guidelines [\n                      \n                      ], and the DSP protocol (21-ADRW-122) was submitted to the Western Institutional Review Board and was granted an exemption. Data were collected in full accordance with relevant legislation at the time. The study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. The submission does not include personal details or images that may lead to the identification of participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}